The FDA withdrew the emergency use authorization for AstraZeneca’s Covid antibody cocktail Evusheld because it does not work against omicron subvariant XBB.1.5
FDA pulls authorization for AstraZeneca’s Covid antibody drug Evusheld
You May Also Like
The stunning hypocrisy of Bill Barr’s probe into the Russia-Trump investigation
- January 27, 2023
Special counsel John Durham, who then-Attorney General William Barr appointed to probe the origins of the Trump-Russia investigation…
Republican House will vote on bills to curtail abortion and immigration
- January 11, 2023
House Republicans plan to vote on bills to curtail abortion and immigration with their new majority, though a…
Why we’ve been seeing the northern lights so often lately
- September 16, 2024
The recent geomagnetic storm allowed auroras to be visible across a much wider area, reaching into places like…
White House declares ‘major disaster’ in California; hazardous roads plague Sierra, Bay Area – San Francisco Chronicle
- January 16, 2023
White House declares ‘major disaster’ in California; hazardous roads plague Sierra, Bay Area San Francisco Chronicle Joe Biden Declares…
Biden administration moves to curb credit card late fees
- February 1, 2023
The Biden administration on Wednesday proposed new rules that would limit the fees credit card companies charge for…
The US economy still seems to be avoiding a recession
- September 1, 2023
Federal Reserve Chairman Jerome Powell speaks during a news conference on July 26, 2023 in Washington, DC. |…